Omalizumab induced lichenoid drug eruption triggered by sun exposure
| dc.authorid | 0000-0003-3504-9886 | |
| dc.contributor.author | Kemeriz, Funda | |
| dc.contributor.author | Acar, Emine Müge | |
| dc.contributor.author | Ordu, Melike | |
| dc.date.accessioned | 2020-09-22T05:35:39Z | |
| dc.date.available | 2020-09-22T05:35:39Z | |
| dc.date.issued | 2020 | |
| dc.department | Tıp Fakültesi | |
| dc.description | *Kemeriz, Funda ( Aksaray, Yazar ) *Ordu, Melike ( Aksaray, Yazar ) | |
| dc.description.abstract | Dear Editor Omalizumab is a humanized monoclonal antibody against human immunoglobulin E that is mainly indicated in asthma, allergic rhinitis, chronic spontaneous urticaria and is being increasingly used for other dermatological diseases, including atopic dermatitis, mastocytosis, hyper-IgE syndrome, and bullous pemphigoid.1,2 Rare cutaneous side effects, such as itching, skin rash, urticaria, and photosensitivity, have been reported to be associated with omalizumab use. | |
| dc.identifier.doi | 10.1111/dth.13542 | |
| dc.identifier.endpage | - | en_US |
| dc.identifier.issn | 1396-0296 | |
| dc.identifier.issue | 4 | en_US |
| dc.identifier.other | Article number e13542 | |
| dc.identifier.pmid | 32385946 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | - | en_US |
| dc.identifier.uri | https:/dx.doi.org/10.1111/dth.13542 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12451/7677 | |
| dc.identifier.volume | 33 | en_US |
| dc.identifier.wos | WOS:000535125400001 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Blackwell Publishing Inc. | |
| dc.relation.ispartof | Dermatologic Therapy | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/embargoedAccess | |
| dc.subject | Antihistaminic Agent | |
| dc.subject | Omalizumab | |
| dc.subject | Steroid | |
| dc.title | Omalizumab induced lichenoid drug eruption triggered by sun exposure | |
| dc.type | Letter |
